Community/Retail

The process of becoming certified in itself instills a greater sense of belonging in pharmacy among technicians.

Oriahnn is the first FDA-approved nonsurgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women

How did switching from name brand to generic cause a child’s death?

Pharmacy Times® spoke with Jennifer Craig, PharmD, CSP, about Skin Cancer Awareness Month and the importance of skin care.

A new law approved in Minnesota this week expands pharmacists’ authority by allowing them to administer FDA-authorized COVID-19 or SARS-CoV-2 vaccines when they become available.

Artificial intelligence will inevitably play a major role in hub services, improving efficiency and speed to therapy.

Pharmacy Times® interviewed James Krellenstein, co-Founder, PrEP4All Collaboration and Organizer, The COVID-19 Working Group, to discuss the development of PrEP for the COVID-19 pandemic.

FDA has granted Fast Track designation to Cardiff Oncology’s onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.

Pharma companies that shift their attention to what providers, payers, and patients are asking for will profit from the growing worldwide market on preventative care.

Today, we’re celebrating the work of Dan McCoy, PharmD, a pharmacist at CVS in Madison, Wisconsin.

The second annual States Forum on Pharmacist Birth Control Services recently was held by the Birth Control Pharmacist project in partnership with the National Alliance of State Pharmacy Associations (NASPA).

Despite triptan availability as a migraine-specific rescue, the global burden of migraine morbidity remains high.

New York Governor Andrew Cuomo announced last week that New York will launch a COVID-19 testing pilot program with a goal of conducting 7000 tests per week.

A study released today demonstrated that tocilizumab has been shown to significantly improve survival outcomes for patients with COVID-19.

Many patients are under the false assumption that there are no risks or potential drug interactions posed by taking OTC medications.

Pharmacists can leverage EHR to compare and contrast medication lists, link medications to patient problems, and evaluate effectiveness and adverse drug events.

Today, we’re celebrating Bailey Dodd, PharmD, and Macie Sobers, PharmD, both pharmacists at Walgreens in Birmingham, Alabama.

Pharmacists are routinely putting others ahead of themselves and may not be sure how to find time for self-care.

The FDA recently announced its approval of a vaginal gel that acts as a method of contraception for women. It is the first non-hormonal, vaginal pH regulator contraceptive to be approved by the FDA.

The work and expertise of a drug utilization pharmacist should be empowered and integrated earlier into a recall process.

Pharmacy Times spoke with Ron Lanton III, Esq, a regulatory and government affairs professional, about how COVID-19 could lead to more expanded practice laws for pharmacists across the country.

Although most children admitted to pediatric ICUs for COVID-19 had underlying conditions, children, teens, and young adults are at a greater risk for severe complications than researchers had previously believed.

Why was a customer prescribed an allergy medication when she was expecting a pain pill?

Today, we’re celebrating the work of Hussain Abdulwahab, MPharm, a pharmacist in Sweden.

Because of continuing social distancing policies and stay-at-home orders, many families have been unable to grieve their family members at funerals or other family gatherings.

Mental health first aid trains participants to recognize risk factors and warning signs for mental health and addiction concerns.

The online resource center will host a webinar series and provide comprehensive coverage and updates on COVID-19 through Pharmacy Times®.

John Beckner, RPh, Senior Director of Strategic Initiatives at NCPA, discusses the role of the community pharmacy in the age of COVID-19 in supporting current health care efforts, such as continuing immunizations and managing the effects of the pandemic on patients.

The Secretary of HHS, Alex M. Azar II, clarified in a statement that the PREP Act preempts state licensing laws that place restrictions on pharmacists’ ability to order and administer COVID-19 tests.

Today, we’re celebrating Kevin McCullough, PharmD, and Brandi McCullough, PharmD, owners of 5 pharmacies in rural Missouri.